New drug shows promise for severe hair loss in early trial
NCT ID NCT06060977
First seen Feb 11, 2026 · Last updated May 23, 2026 · Updated 10 times
Summary
This study tested a new medicine called IMG-007 in 29 adults with alopecia areata who had lost at least half of their scalp hair. The main goal was to check if the drug is safe. Researchers also measured hair regrowth using a special tool. The trial was completed, but results are not yet available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALOPECIA AREATA(AA) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Alliance Clinical Research of Tampa
Tampa, Florida, 33615, United States
-
Centre de Recherche Saint-Louis
Québec, Quebec, G1W4R4, Canada
-
Dawes Fretzin Clinical Resarch Group, LLC
Indianapolis, Indiana, 47906, United States
-
Dermatology Specialists of Spokane
Spokane, Washington, 99202, United States
-
Great Lakes Research Group Inc.
Bay City, Michigan, 48706, United States
-
Guelph Dermatology Research
Guelph, Ontario, N1L0B7, Canada
-
Innovaderm Research Inc.
Montreal, Canada
-
Lahey Hospital & Medical Center
Burlington, Massachusetts, 01803, United States
-
Northwest Arkansas Clinical Trials Center, PLLC/ Hull Dermatology P.A.
Rogers, Arkansas, 72758, United States
-
Options Research Group
West Lafayette, Indiana, 47906, United States
-
Research Toronto
Toronto, Ontario, M2W2N4, Canada
-
SimcoMed Health Ltd.
Barrie, Ontario, L4M7G1, Canada
-
Skin Cancer and Dermatology Institute
Reno, Nevada, 89509, United States
-
Skin Health
Cobourg, Ontario, K9A0Z4, Canada
-
Skin Search of Rochester, Inc.
Rochester, New York, 14623, United States
-
Stride Clinical Research LLC
Sugar Land, Texas, 77479, United States
-
Torrance Clinical Research Institute Inc.
Lomita, California, 90717, United States
Conditions
Explore the condition pages connected to this study.